The insider sales cluster is routine in size relative to market cap and lacks the informational content of a buy cluster. Monitor the next quarterly filing for any change in business outlook, but this filing alone does not warrant a bearish stance.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20- T+0 · Aug 28 $600.65entry
- T+1 · 3mo ago −1.11%α −0.81% · $593.99
- T+5 · 2mo ago −1.56%α −1.67% · $591.29
- T+20 · 7w ago +2.55%α +3.03% · $615.94
- T+55 · todayOpen
- T+60 · in 6d Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Four Medpace insiders, including the CEO, CFO, and two directors, sold a total of $10.0M in shares over a one-week window. The CEO's sales ($4.1M) and the CFO's sale ($2.1M) are notable for their size and seniority, but the total represents only ~0.06% of the company's $17.1B market cap, falling below the 0.1% materiality threshold. The sales are likely driven by routine portfolio diversification and tax planning, not a bearish signal on fundamentals, especially given the weak predictive power of insider sales clusters per the academic literature.
Key Financial Metrics
Key Facts
- Four insiders sold a total of $10.0M in shares over 7 days.
- CEO August Troendle sold $4.1M, CFO Kevin Brady sold $2.1M.
- Total sales represent ~0.06% of Medpace's $17.1B market cap.
- Insider sales clusters are weak predictors of future stock performance per academic literature.
- No open-market purchases were made by any insider during the window.
Financial Impact
Total insider sales of $10.0M represent 0.06% of market cap, immaterial from a supply/demand perspective.
Risk Factors
- CEO selling a material portion of his personal holdings could signal a lack of confidence, though the dollar amount is small relative to his likely total stake.
- Broader CRO sector headwinds could be a non-public reason for the sales, but no evidence of this in the filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-MEDP-1787901024692 |
Track record
24 reports on MEDP
5 of 6 bullish or bearish reports moved the stock their way by T+1. Best: +11.09% at T+20 after the Dec 4, 2025 report. 5 of 6 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Bearish 4/10 Entry $652.28 Now $648.20 +0.62% settles Nov 17
- Nov 13, 20263d ago SC 13G Neutral 4/10 Entry $653.94 to $648.20 Now $648.20 −0.88% ▼ −0.88% +1.03% vs SPY
- Nov 2, 202614d ago Insider Cluster Bearish 4/10 Entry $663.49 to $656.77 Now $648.20 +2.30% ▲ +1.01% +2.66% vs SPY
- Oct 29, 202618d ago 144 Neutral 2/10 Entry $677.56 to $652.01 Now $648.20 −4.33% ▼ −3.77% −2.00% vs SPY
- Oct 27, 202620d ago 144 Neutral 2/10 Entry $673.79 to $692.68 Now $648.20 −3.80% ▲ +2.80% +2.46% vs SPY
- Oct 26, 202621d ago 144 Neutral 2/10 Entry $673.79 to $692.68 Now $648.20 −3.80% ▲ +2.80% +2.46% vs SPY
- Oct 23, 202624d ago Institutional Cluster Bullish 4/10 Entry $669.20 to $676.77 Now $648.20 −3.14% ▲ +1.13% +0.42% vs SPY
- Oct 21, 202626d ago 8-K Bullish 6/10 Entry $653.96 to $669.20 Now $648.20 −0.88% ▲ +2.33% +2.85% vs SPY
- Sep 28, 20267w ago SC 13D/A Neutral 4/10 Entry $622.11 to $624.18 Now $648.20 +4.19% ▲ +0.33% +0.54% vs SPY
- Aug 31, 202611w ago Insider Cluster Neutral 2/10 Entry $583.21 to $593.02 Now $648.20 +11.14% ▲ +1.68% +1.24% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers